Tag: Voriconazole
Showing 10 of 15:
-
Spectrum of voriconazole-associated periostitis in clinical characteristics, diagnosis and management.
References 1. Enoch DA, Yang H, Aliyu SH, Micallef C. the changing epidemiology of invasive fungal infections. Methods Mol Biol. 2017;1508:17–65. – PubMed 2. Shi C, Xiao Y, Mao Y, Wu J, Lin N. Voriconazole: a review of population pharmacokinetic analyses. Clin Pharmacokinet. 2019;58:687–703. – PubMed 3. Theuretzbacher U, Ihle F, Derendorf H. Pharmacokinetic/pharmacodynamic profile […]
-
Voriconazole-associated periostitis: Pathophysiology, risk factors, clinical manifestations, diagnosis, and management.
-
Voriconazole-induced periostitis
The main hypothesis that explains how voriconazole can generate or trigger this periostitis is subacute fluoride toxicity, secondary to the use of the antifungal agent. Voriconazole contains in its structure three fluorine atoms that represent 16.25% of its molecular weight. This means that a dose of 400 mg contains 65 mg of fluorine (6). In […]
-
Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole.
-
Impairing fluoride export of Aspergillus fumigatus mitigates its voriconazole resistance
-
Optimal trough concentration of voriconazole with therapeutic drug monitoring in children: A systematic review and meta-analysis.
-
Correlation of pain and fluoride concentration in allogeneic hematopoietic stem cell transplant recipients on voriconazole
-
Fluorosis and periostitis deformans as complications of prolonged voriconazole treatment
-
Voriconazole
-
Voriconazole-induced periostitis after allogeneic stem cell transplantation